| Previous Close | 0.275 |
| Open | 0.275 |
| Volume | 214,800 |
| Avg. Volume (3M) | 473,701 |
| Market Cap | 85,560,160 |
| Price / Sales | 1.97 |
| Price / Book | 0.900 |
| 52 Weeks Range |
| Profit Margin | -11.85% |
| Operating Margin (TTM) | 2.64% |
| Diluted EPS (TTM) | -0.030 |
| Quarterly Revenue Growth (YOY) | 85.40% |
| Total Debt/Equity (MRQ) | 3.92% |
| Current Ratio (MRQ) | 3.03 |
| Operating Cash Flow (TTM) | 16.99 M |
| Levered Free Cash Flow (TTM) | -4.86 M |
| Return on Assets (TTM) | -4.45% |
| Return on Equity (TTM) | -6.60% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (MY) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | ADVENTA | - | - |
Stockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.63 |
|
Adventa Bhd is engaged in the business of medical services and related supplies manufacturing. The company's segments include Healthcare Business, Warehousing provider, and Corporate. It generates maximum revenue from the Healthcare Business segment. The healthcare business segment comprises the supply of healthcare and related products and services to hospitals, healthcare centers, and pharmacies. Previously, it also included the renal dialysis business which is both for home and center-based treatments, serving both the domestic and export markets. Geographically, it derives a majority of its revenue from Malaysia. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 71.46% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 01 Oct 2024 | Announcement | Adventa Berhad ("the Company") - Appointment of New External Auditors of the Company |
| 06 Sep 2024 | Announcement | Adventa Berhad ("the Company") - Resignation of External Auditors of the Company |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 14 Jan 2020 | 30 Dec 2019 | 22 Jan 2020 | 0.07 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2020 | 0.070 | 1 | 4.58 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |